Literature DB >> 8546695

The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

S Lusa1, M Jauhiainen, J Metso, P Somerharju, C Ehnholm.   

Abstract

1. Phospholipid transfer protein (PLTP) mediates conversion of high-density lipoprotein (HDL3) to large particles, with concomitant release of apolipoprotein A-I (apoA-I). To study the mechanisms involved in this conversion, reconstituted HDL (rHDL) particles containing either fluorescent pyrenylacyl cholesterol ester (PyrCE) in their core (PyrCE-rHDL) or pyrenylacyl phosphatidylcholine (PysPC) in their surface lipid layer (PyrPC-rHDL) were prepared. Upon incubation with PLTP they behaved as native HDL3, in that their size increased considerably. 2. When PyrPC-rHDL was incubated with HDL3 in the presence of PLTP, a rapid decline of the pyrene excimer/monomer fluorescence ratio (E/M) occurred, demonstrating that PLTP induced mixing of the surface lipids of PyrPC-rHDL and HDL3. As this mixing was almost complete before any significant increase in HDL particle size was observed, it represents PLTP-mediated phospholipid transfer or exchange that is not directly coupled to the formation of large HDL particles. 3. When core-labelled PyrCE-rHDL was incubated in the presence of PLTP, a much slower, time-dependent decrease of E/M was observed, demonstrating that PLTP also promotes mixing of the core lipids. The rate and extent of mixing of core lipids correlated with the amount of PLTP added and with the increase in particle size. The enlarged particles formed could be visualized as discrete, non-aggregated particles by electron microscopy. Concomitantly with the appearance of enlarged particles, lipid-poor apoA-I molecules were released. These data, together with the fact that PLTP has been shown not to mediate transfer of cholesterol esters, strongly suggest that particle fusion rather than (net) lipid transfer or particle aggregation is responsible for the enlargement of HDL particles observed upon incubation with PLTP.4.ApoA-I rHDL, but not apoA-II rHDL, were converted into large particles, suggesting that the presence of apoA-I is required for PLTP-mediated HDL fusion. A model for PLTP-mediated enlargement of HDL particles is presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546695      PMCID: PMC1216894          DOI: 10.1042/bj3130275

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

Review 1.  Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.

Authors:  J C Fruchart; G Ailhaud
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

2.  Complete cDNA encoding human phospholipid transfer protein from human endothelial cells.

Authors:  J R Day; J J Albers; C E Lofton-Day; T L Gilbert; A F Ching; F J Grant; P J O'Hara; S M Marcovina; J L Adolphson
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

3.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

4.  Activation of human plasma lipid transfer protein by apolipoproteins.

Authors:  T Ohnishi; S Yokoyama
Journal:  Biochemistry       Date:  1993-05-18       Impact factor: 3.162

5.  High density lipoprotein conversion mediated by human plasma phospholipid transfer protein.

Authors:  A Y Tu; H I Nishida; T Nishida
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

6.  Cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein A-I (LpA-I) increases with particle size but cholesterol transfer from LpA-I to lipoproteins decreases with size.

Authors:  G Agnani; Y L Marcel
Journal:  Biochemistry       Date:  1993-03-16       Impact factor: 3.162

7.  Human plasma phospholipid transfer protein causes high density lipoprotein conversion.

Authors:  M Jauhiainen; J Metso; R Pahlman; S Blomqvist; A van Tol; C Ehnholm
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

8.  Studies of the lipid binding characteristics of the apolipoproteins from human high density lipoprotein. II. Calorimetry of the binding of apo AI and apo AII with phospholipids.

Authors:  M Rosseneu; F Soetewey; G Middelhoff; H Peeters; W V Brown
Journal:  Biochim Biophys Acta       Date:  1976-07-20

9.  Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).

Authors:  A von Eckardstein; G Castro; I Wybranska; N Theret; P Duchateau; N Duverger; J C Fruchart; G Ailhaud; G Assmann
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma.

Authors:  N Duverger; D Rader; P Duchateau; J C Fruchart; G Castro; H B Brewer
Journal:  Biochemistry       Date:  1993-11-23       Impact factor: 3.162

View more
  35 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Authors:  Mark S Borja; Kit F Ng; Angela Irwin; Jaekyoung Hong; Xing Wu; Daniel Isquith; Xue-Qiao Zhao; Bryan Prazen; Virginia Gildengorin; Michael N Oda; Tomáš Vaisar
Journal:  J Lipid Res       Date:  2015-08-07       Impact factor: 5.922

Review 3.  Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary.

Authors:  Dhruv Kazi; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

4.  Effects of cholesterol on thermal stability of discoidal high density lipoproteins.

Authors:  Shobini Jayaraman; Sangeeta Benjwal; Donald L Gantz; Olga Gursky
Journal:  J Lipid Res       Date:  2009-08-21       Impact factor: 5.922

5.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

Authors:  Giorgio Cavigiolio; Baohai Shao; Ethan G Geier; Gang Ren; Jay W Heinecke; Michael N Oda
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

6.  Setting the course for apoAII: a port in sight?

Authors:  Henry J Pownall; Baiba K Gillard; Antonio M Gotto
Journal:  Clin Lipidol       Date:  2013-10

7.  Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.

Authors:  Ailing Ji; Joanne M Wroblewski; Nancy R Webb; Deneys R van der Westhuyzen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-24       Impact factor: 8.311

8.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

Review 9.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

10.  Degradation of pyrene-labelled phospholipids by lysosomal phospholipases in vitro. Dependence of degradation on the length and position of the labelled and unlabelled acyl chains.

Authors:  S Lusa; M Myllärniemi; K Volmonen; M Vauhkonen; P Somerharju
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.